The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.675
Bid: 1.60
Ask: 1.75
Change: 0.00 (0.00%)
Spread: 0.15 (9.375%)
Open: 1.675
High: 1.75
Low: 1.675
Prev. Close: 1.675
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: eve Sleep shares awakened by DFS Furniture deal

Wed, 23rd Feb 2022 11:41

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

eve Sleep PLC, up 91% at 3.35 pence, 12-month range 1.60p-7.60p. The mattress retailer has entered into a partnership with sofa retailer DFS Furniture PLC. The partnership will initially cover the dfs.co.uk website, which brings in 2.7 million visitors every month, from March 3. Later in the year, eve Sleep products including mattresses and bed frames will be available in the DFS showroom estate. The range will be expanded "at a later date". DFS shares are down 1.6%.

----------

Genedrive PLC, up 22% at 17.70p, 12-month range 14.00p-157.90p. The molecular diagnostics company says it has entered into several distribution agreements for its rapid Covid-19 test-kit, covering Spain, Portugal, Oman and the United Arab Emirates

----------

AIM - LOSERS

----------

Peel Hunt Ltd, down 16% at 149.00p, 12-month range 148.00p-235.00p. The corporate broker and investment bank issues profit warning saying concerns pertaining to inflation and interest rates as well as global geopolitical tensions have dented market conditions and investor sentiment. As such, Peel Hunt says it has seen a number of deals delayed and capital markets activity early in 2022 has been "particularly challenging". Peel Hunt expects annual revenue to be marginally below bottom of previous guided range and earnings will be "commensurately lower than current market expectations".

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
22 Oct 2020 17:42

IN BRIEF: Genedrive Completes Assay Design For Covid Testing Solution

IN BRIEF: Genedrive Completes Assay Design For Covid Testing Solution

Read more
30 Sep 2020 17:56

IN BRIEF: Genedrive's Covid-19 Kit Gets Approval In South Africa

IN BRIEF: Genedrive's Covid-19 Kit Gets Approval In South Africa

Read more
30 Sep 2020 17:21

Genedrive gets approval for Covid-19 kit in South Africa

(Sharecast News) - Molecular diagnostics company Genedrive announced on Wednesday that its 'Genedrive 96' SARS-CoV-2 kit has received approval from the South African Health Products Regulatory Authority, having been submitted for evaluation in June.

Read more
25 Sep 2020 09:07

Genedrive Completes Testing Of Beckman's RNA Extraction With Covid Kit

Genedrive Completes Testing Of Beckman's RNA Extraction With Covid Kit

Read more
4 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

Read more
10 Jul 2020 11:47

IN BRIEF: Genedrive Expects Lower Revenue, Develops Covid Software

IN BRIEF: Genedrive Expects Lower Revenue, Develops Covid Software

Read more
10 Jul 2020 10:43

UK WINNERS & LOSERS SUMMARY: IPF Rises As June Collections Improve

UK WINNERS & LOSERS SUMMARY: IPF Rises As June Collections Improve

Read more
10 Jul 2020 10:15

Genedrive revenues tumble as Covid-19 hits pre-existing business activities

(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tumble in the year ended 30 June due to the impact of the Covid-19 pandemic on pre-existing business activities.

Read more
22 May 2020 13:16

Genedrive gets CE-mark for Covid-19 test kit

(Sharecast News) - Molecular diagnostics company Genedrive announced on Friday that its 'Genedrive 96 SARS-CoV-2 Kit' was now CE-IVD marked, and available for commercial sale across the European Union, including the UK.

Read more
12 May 2020 15:35

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth

Read more
5 May 2020 18:44

Genedrive Placing Succeeds In Hitting GBP7 Million Placing Goal

Genedrive Placing Succeeds In Hitting GBP7 Million Placing Goal

Read more
5 May 2020 17:04

Genedrive To Raise GBP7 Million To Fund Assay Test Development

Genedrive To Raise GBP7 Million To Fund Assay Test Development

Read more
4 May 2020 18:41

Genedrive Hepatitis Test Kit Prequalified By World Health Organisation

Genedrive Hepatitis Test Kit Prequalified By World Health Organisation

Read more
1 May 2020 16:17

Genedrives completes manufacturing milestone for Covid-19 test

(Sharecast News) - Near-patient molecular diagnostics company Genedrive has completed the last significant manufacturing milestone in the co-development of the 'Genedrive 96 SARS-CoV-2' kit with Cytiva, it announced on Friday.

Read more
1 May 2020 13:28

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.